Analysis group,Analysis number,Analysis name,Analysis group name,Data source,Data source eligibility,Data type,Log-scale data,Outcome,Intervention grouping,Experimental intervention,Control intervention,Subgroup by,Filter criteria,Experimental group label,Control group label,Statistical method,Effect measure,Unit of effect measure,Analysis model,Heterogeneity estimator,Tau² CI,Subgroup estimates,Overall estimates,Test for subgroup differences,Prediction interval,Swap event and non-event,CI method,CI/PI level,Experimental cases,Experimental N,Control cases,Control N,Mean,CI start,CI end,PI start,PI end,Heterogeneity Tau²,Tau² CI start,Tau² CI end,Heterogeneity Chi²,Heterogeneity df,Heterogeneity P,Heterogeneity I²,Effect Z,Effect T,Effect P,Subgroup Chi²,Subgroup df,Subgroup P,Subgroup I²,ID
1,1,Functional disability component related to tremor,Topiramate versus placebo/open control,Custom input,"#N/A",Continuous,false,,,,,,,,,IV,Mean Difference,,Fixed effect,"#N/A",false,true,false,false,false,false,Wald,95%,,,,,,,,,,,,,,,,,,,,,,,,analysis:459640877448978527
1,2,Withdrawals,Topiramate versus placebo/open control,Custom input,"#N/A",Dichotomous,true,,,,,,,,,MH,Risk Ratio,,Fixed effect,"#N/A",false,true,false,false,false,false,Wald,95%,,,,,,,,,,,,,,,,,,,,,,,,analysis:459640877451075688
